title: The Slippery Slope of Broadening Treatment Eligibility and Weak End Points: Defending the Oligo in Oligometastatic Non-Small-Cell Lung Cancer.
authors.affiliation: Swedish Cancer Institute, Global Resource for Advancing Cancer Education (GRACE), Seattle, Washington.
authors.forename: Howard Jack
authors.initials: HJ
authors.lastname: West
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D059146:Metastasectomy; D009362:Neoplasm Metastasis; D018579:Patient Selection